Skip to content

This content is in French.

Efficacy and safety of etrolizumab in the treatment of inflammatory bowel disease: a meta-analysis

11 septembre 2024

Efficacy and safety of etrolizumab in the treatment of inflammatory bowel disease: a meta-analysis
This study explores the efficacy and safety of etrolizumab in the treatment of inflammatory bowel disease (IBD) through a meta-analysis.

Sign in to read the rest

Reserved for healthcare professionals, free registration.

Scientific reference

Yong Gang Dai 1 2, Dajuan Sun 1, Jiahui Liu 1, Xiunan Wei 1, Lili Chi 1, Hongya Wang 2

View the source